Tempus AI COO Ryan Fukushima sells 20,000 shares of stock

In a regulatory filing, Tempus AI (TEM) disclosed that COO Ryan Fukushima sold 20,000 shares of the company's stock. The stock was sold at an average price of $62.50, for a total value of $1.2M. Following the completion of the transaction, the executive now directly owns 962,442 shares of the company's stock, valued at approximately $60.15M.
Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders' Hot Stocks on TipRanks >>
Read More on TEM:
Tempus AI (TEM) Stock Surges as TD Cowen Reinstates Buy After Ambry Deal
Unusually active option classes on open February 5th
AMD, Spotify downgraded: Wall Street's top analyst calls
Tempus AI reinstated with a Buy at TD Cowen
Unusually active option classes on open February 4th

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Business Wire

14 hours ago

• Business Wire

INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Tempus AI, Inc. (NASDAQ: TEM) common stock between August 6, 2024 and May 27, 2025, inclusive (the 'Class Period'), have until August 12, 2025 to seek appointment as lead plaintiff of the Tempus AI class action lawsuit. Captioned Shouse v. Tempus AI, Inc. Tempus AI class action lawsuit charges Tempus AI and certain of Tempus AI's top executives with violations of the Securities Exchange Act of 1934. If you suffered substantial losses and wish to serve as lead plaintiff of the Tempus AI class action lawsuit, please provide your information here: CASE ALLEGATIONS: Tempus AI is a technology company advancing precision medicine through the practical application of artificial intelligence, including generative AI. The Tempus AI class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) Tempus AI inflated the value of contract agreements, many of which were with related parties, included non-binding opt-ins and/or were self-funded; (ii) the credibility and substance of Tempus AI's joint venture with SoftBank Group Corporation was at risk because it gave the appearance of 'round-tripping' capital to create revenue for Tempus AI; (iii) Tempus AI-acquired Ambry Genetics Corporation had a business model based on aggressive and potentially unethical billing practices that risked scrutiny and unsustainability; (iv) AstraZeneca PLC had reduced its financial commitments to Tempus AI through a questionable 'pass-through payment' via a joint agreement between it, Tempus AI, and Pathos AI, Inc.; and (v) the above issues revealed weakness in core operations and revenue prospects. The Tempus AI class action lawsuit further alleges that on May 28, 2025, Spruce Point Capital Management, LLC issued research report on Tempus AI that raised numerous red flags over Tempus AI's management, operations, and financial reporting. On this news, the price of Tempus AI stock fell more than 19%, according to the complaint. THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased Tempus AI common stock during the Class Period to seek appointment as lead plaintiff in the Tempus AI class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the Tempus AI class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the Tempus AI class action lawsuit. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Tempus AI class action lawsuit. ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world's leading law firms representing investors in securities fraud and shareholder litigation. Our Firm has been ranked #1 in the ISS Securities Class Action Services rankings for four out of the last five years for securing the most monetary relief for investors. In 2024, we recovered over $2.5 billion for investors in securities-related class action cases – more than the next five law firms combined, according to ISS. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs' firms in the world, and the Firm's attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information: Past results do not guarantee future outcomes. Services may be performed by attorneys in any of our offices.

Yahoo

16 hours ago

• Yahoo

Why Credo Technology Stock Was Marching Higher This Week

An analyst raised his price target on the highly specialized tech company. He maintained his buy recommendation as he did so. 10 stocks we like better than Credo Technology Group › Data center connectivity solutions company Credo Technology (NASDAQ: CRDO) won attention from many stock market participants this week, thanks in no small part to an analyst flagging it as a top pick in the small and mid-cap categories. With this pleasant tailwind at its back, Credo's share price was a robust 16%-plus higher as of late Thursday night, according to data compiled by S&P Global Market Intelligence. The pundit behind the price target boost was TD Cowen's Joshua Buchalter, who on Wednesday upped his fair value assessment on Credo stock to $95 per share; previously he had tagged it as potentially being worth $85. In making the change he left his buy rating intact. Not only that; according to reports, Buchalter and TD Cowen now consider Credo his company's best small- or mid-cap idea for 2025. That's meaningful, given the many stocks in those two categories. In his Credo update, the analyst was particularly enthusiastic about the effect of artificial intelligence (AI) demand on Credo's business. Many companies are racing to enhance their products and services with AI functionalities, and data centers must upgrade to handle the huge resource needs of the technology. It hasn't escaped Buchalter's notice that Credo is also a high-growth and high-margin company, and it's entirely possible that management will be able to maintain (or even exceed) the torrid growth it has shown of late. This company's stock is a fine buy on the continued rise of AI, and the prognosticator's optimism is justified. Before you buy stock in Credo Technology Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Credo Technology Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $659,171!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $891,722!* Now, it's worth noting Stock Advisor's total average return is 995% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why Credo Technology Stock Was Marching Higher This Week was originally published by The Motley Fool

Yahoo

17 hours ago

• Yahoo

TD Cowen Remains Bullish on MicroStrategy (MSTR)

MicroStrategy Incorporated (NASDAQ:MSTR) is one of the 13 Crypto Stocks with the Highest Upside Potential. On June 17, TD Cowen analyst Lance Vitanza maintained a Buy rating on MicroStrategy Incorporated (NASDAQ:MSTR) with a price target of $590. The rating update came after MicroStrategy Incorporated (NASDAQ:MSTR) announced that it acquired 10,100 Bitcoins in the June 9 to June 15 period for around $1.05 billion. The average price of the Bitcoins came up to $104,080 per bitcoin, as per Strategy's 8-K filing with the US Securities and Exchange Commission (SEC). After the acquisition, the company holds 592,100 Bitcoins at an average price of $70,666, collectively valued at over $63 billion. A software engineer wearing a headset, collaborating with a remote team on a project. MicroStrategy Incorporated (NASDAQ:MSTR) spent around $41.84 billion to acquire these Bitcoins and conducted the latest acquisition using the proceeds from its preferred share offering. The company's total Bitcoin holdings now represent around 2.8% of the total Bitcoin supply of 21 million. MicroStrategy Incorporated (NASDAQ:MSTR) engages in the development of the Bitcoin network through its operations in technology, financial markets, and advocacy. It is the world's largest corporate holder of Bitcoin. While we acknowledge the potential of MSTR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data